胰腺疾病的EUS指导干预疗法
Rongmin Xu1, Kai Zhang1, Nan Ge1
1Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in medicine
|January 23, 2024
概括
内镜超声波 (EUS) 从诊断发展为胰腺疾病的治疗. 本综述分析了EUS的技术进步及其在治疗胰腺疾病中的治疗应用.
科学领域:
- 胃肠病学和医疗技术
背景情况:
- 内镜超声波 (EUS) 整合了内镜和超声波,用于检查消化系统.
- EUS是胰腺疾病的领先诊断工具,提供独特的优势.
- 40多年来,EUS已经从诊断到治疗的角色过渡.
研究的目的:
- 提供对EUS当前用于胰腺疾病治疗的技术方法的全面审查.
- 分析EUS在治疗胰腺疾病中的不断变化的作用.
主要方法:
- 对胰腺疾病EUS技术进步的文献综述.
- 分析EUS的诊断和治疗应用.
- 检查EUS作为手术的替代或辅助疗法.
主要成果:
- 欧盟卫队已经取得了显著的进步,扩大其能力超出了诊断范围.
- EUS越来越多地被用作胰腺疾病的治疗方式.
- 欧盟外科手术系统 (EUS) 为传统外科手术提供了一个突出的替代方案或辅助方案.
结论:
- EUS技术已经改变了胰腺疾病的管理.
- 多种治疗方法的整合使得胰腺护理中的EUS恢复活力.
- 在胰腺疾病管理的轨迹中,EUS在胰腺疾病管理中发挥着动态和不断扩大的作用.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Endoscopic Procedures V: ERCP
232
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
232
Acute Pancreatitis II: Clinical Manifestations and Management
125
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
125


